首页> 外文期刊>Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology >Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy.
【24h】

Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy.

机译:伴有甲状腺疾病患者甲状旁腺病变的术前评估:高分辨率超声检查和双相锝 99m sestamibi 闪烁显像的作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim of this study was to evaluate the sensitivity and usefulness of high resolution ultrasonography (US) and dual phase technetium-99m sestamibi (Tc-MIBI) scintigraphy in the preoperative localization of parathyroid lesions in patients with or without thyroid disease and to define the impact of the presence of thyroid disease on these methods. Preoperative US and scintigraphy were performed on 52 patients with primary hyperparathyroidism. Age, gender, preoperative parathyroid hormone level, serum calcium level, serum phosphate level, diameter, location, associated with thyroid abnormality, and results of parathyroid exploration were determined in all patients. The results of US and Tc-MIBI imaging were analyzed and compared with surgical and histopathologic findings. At surgery, 56 parathyroid lesions were found in 52 patients (9 men, 43 women), the parathyroid lesion was solitary (47 adenomas, two hyperplasias), in 2 patients double adenomas were present, in 1 patient three glands was affected by hyperplasia. Twenty-seven patients had concomitant thyroid disease. The overall sensitivity of US and Tc-MIBI scintigraphy was 84 and 73, respectively. In patients without thyroid disease, the sensitivity of these techniques was 90 and 75, respectively. In patients with thyroid disease, the sensitivity was 78 and 70, respectively. In patients with thyroid disease, the combined sensitivity of these techniques was 89. These results allow the conclusion that, in experienced hands, US is a highly sensitive technique. Especially in patients with no thyroid pathology and typical located gland, US alone should be used as a first step for preoperative localization of parathyroid lesions. When negative, Tc-MIBI scintigraphy is suggested. In patients with concomitant thyroid disease, the combination of US and Tc-MIBI scintigraphy represents a reliable localization technique.
机译:本研究的目的是评估高分辨率超声检查 (US) 和双相锝-99m sestamibi (Tc-MIBI) 闪烁显像在有或没有甲状腺疾病的患者甲状旁腺病变的术前定位中的敏感性和有用性,并确定甲状腺疾病的存在对这些方法的影响。对 52 例原发性甲状旁腺功能亢进症患者进行术前超声和闪烁显像。检测所有患者的年龄、性别、术前甲状旁腺激素水平、血清钙水平、血清磷酸盐水平、直径、位置、甲状旁腺异常相关、甲状旁腺探查结果。分析了超声和Tc-MIBI成像的结果,并与手术和组织病理学结果进行了比较。手术时,52例患者(男9例,女43例)发现甲状旁腺病变56例,甲状旁腺病变单发(腺瘤47例,增生2例),2例患者存在双腺瘤,1例患者3个腺体受增生影响。27例患者伴有甲状腺疾病。US和Tc-MIBI闪烁显像的总体敏感性分别为84%和73%。在没有甲状腺疾病的患者中,这些技术的敏感性分别为 90% 和 75%。在甲状腺疾病患者中,敏感性分别为 78% 和 70%。在甲状腺疾病患者中,这些技术的综合敏感性为89%。这些结果可以得出结论,在有经验的人手中,US是一种高度敏感的技术。特别是在无甲状腺病变且位于典型腺体的患者中,应单独使用超声作为术前定位甲状旁腺病变的第一步。当阴性时,建议进行 Tc-MIBI 闪烁显像。在合并甲状腺疾病的患者中,超声和 Tc-MIBI 闪烁显像的组合代表了一种可靠的定位技术。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号